RxDoctor Payments Data

Amy James

Nurse Practitioner · Tawas City, MINPI 1578843942

Payments from drug & device makers

$1,733in general payments, 2019–2025

Across 117 payments — averaging $14.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$307
  • AbbVie$286
  • Lilly USA, LLC$207
  • Pfizer$119
  • Lundbeck LLC$96
  • AstraZeneca$75
  • plus $644 from 21 others

What the payments were for

  • Food & beverage$1,733100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,733 in reported general payments places this provider in the 85th percentile of 3,351 nurse practitioner providers in Michigan.

See all nurse practitioner providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol88$109,867
EliquisApixaban55$78,581
JardianceEmpagliflozin57$74,823
Spiriva RespimatTiotropium Bromide41$52,016
TrulicityDulaglutide33$51,750
OzempicSemaglutide45$49,369
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$45,597
MounjaroTirzepatide31$42,809
MyrbetriqMirabegron38$34,284
Breztri AerosphereBudesonide/Glycopyr/Formoterol28$33,797
RybelsusSemaglutide16$32,757
XareltoRivaroxaban21$31,400
JanuviaSitagliptin Phosphate17$26,243
Stiolto RespimatTiotropium Br/Olodaterol Hcl21$23,440
Breo ElliptaFluticasone/Vilanterol16$16,563

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat, Stiolto Respimat$27$150,279119 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$75$149,928130 claims
Lilly USA, LLCTrulicity, Mounjaro$207$94,56064 claims
Novo NordiskOzempic, Rybelsus$307$82,12661 claims
PfizerEliquis$119$78,58155 claims
GSKTrelegy Ellipta, Breo Ellipta$27$62,15944 claims
Astellas Pharma US IncMyrbetriq$32$34,28438 claims
Johnson & JohnsonXarelto$14$31,40021 claims
MerckJanuvia$14$26,24317 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,351 nurse practitioner providers in Michigan.

Other nurse practitioner in Tawas City

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →